OncologySelective Glucocorticoid Receptor Modulators (SGRMs) delay castrate-resistant prostate cancer growth.Kach et al. • 2017 Mol Cancer Ther. 2017;16(8):1680-1692. 28428441 October 18, 2018 https://corcept.com/wp-content/uploads/COR-logo.svg 0 0 imc@healthandcommerce.com https://corcept.com/wp-content/uploads/COR-logo.svg imc@healthandcommerce.com2018-10-18 00:00:002018-10-18 00:00:00Selective Glucocorticoid Receptor Modulators (SGRMs) delay castrate-resistant prostate cancer growth.
